John Paulson’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

John Paulson’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,070,000	Closed	-$42.5M	–	117
2016 Q3	$42.5M	Buy	+1,070,000	New	+$11.9M	0.46%	35

John Paulson's TBRA Position: Q4 2016 in Review

John Paulson sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 1,070,000 shares — an estimated $42.5M sold.

John Paulson first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $42.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

John Paulson reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
John Paulson sold 1,070,000 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $42.5M.
John Paulson first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
John Paulson's Tobira Therapeutics, Inc. Common Stock position peaked at $42.5M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Paulson & Co's 13F filing for Q4 2016, filed 14 Feb 2017.